🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
3.310
-0.070 (-2.07%)
Nov 18, 2026, 10:50 AM EST - Market open

Aclaris Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-79.63-64.92-132.07-88.48-86.91-90.87
Depreciation & Amortization
0.410.450.810.860.80.92
Asset Writedown & Restructuring Costs
--86.916.63--
Stock-Based Compensation
11.8212.3810.8620.5415.0414.06
Other Operating Activities
0.12.32.5-27.274.725.09
Change in Accounts Receivable
-4.056.14-4.880.190.140.15
Change in Accounts Payable
-0.158.45-4.19-1.470.373.66
Change in Unearned Revenue
-4.12-3.8223.93---
Change in Other Net Operating Assets
0.43-8.1-3.9410.68-1.7-5.15
Operating Cash Flow
-75.21-47.11-20.08-78.33-67.57-52.13
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.11-0.11-0.12-1.31-0.61-0.31
Sale (Purchase) of Intangibles
--0.83-35.81---
Investment in Securities
-43.4149.31-33.8447.5313.23-167.32
Investing Cash Flow
-43.5248.37-69.7746.2212.63-167.63

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
------11.48
Net Debt Issued (Repaid)
------11.48
Issuance of Common Stock
116.73-80.0327.6372.9239.66
Repurchase of Common Stock
-0.5-0.45-0.41-0.1-0.03-3.12
Other Financing Activities
-2.37-5.42-5.09-0.83--
Financing Cash Flow
113.86-5.8674.5426.7172.87225.05

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-4.86-4.61-15.31-5.417.935.29

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-75.32-47.22-20.2-79.63-68.17-52.44
Free Cash Flow Growth
------
Free Cash Flow Margin
-1176.61%-603.42%-107.89%-254.84%-229.13%-775.65%
Free Cash Flow Per Share
-0.55-0.39-0.26-1.14-1.04-0.92
Levered Free Cash Flow
-50.13-30.63-59.12-37.97-39.31-28.51
Unlevered Free Cash Flow
-50.13-30.63-59.12-37.97-39.31-28.51

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
-7.92.6710.929.39-1.2-1.34
SEC Filings: 10-K · 10-Q